Literature DB >> 10339668

Detection of basic fibroblast growth factor mRNA in urinary bladder cancer: correlation with local relapses.

P Gazzaniga1, O Gandini, A Gradilone, I Silvestri, L Giuliani, M Magnanti, M Gallucci, G Saccani, L Frati, A M Agliano.   

Abstract

Natural history of bladder cancer is characterized by high risk of disease progression even for patients with a clinical diagnosis of superficial disease; in these tumors, the occurrence of local relapse is known to be dependent on the angiogenesis rate. Basic fibroblast growth factor (bFGF), has been described to be elevated in urine and serum of patients with bladder cancer. We investigated the expression of bFGF at mRNA level in a panel of 32 transitional cell tumors of the urinary bladder and in normal bladder tissues used as controls. Expression of bFGF was found elevated in most tumors of high stage, where its presence was found correlated with the occurrence of early local relapses. Furthermore, bFGF was found highly expressed in the majority of tumors showing a high bcl-2 expression rate. Our data suggest that bFGF expression could contribute to the progression of disease; it may provide a prognostic indicator in the identification of patients with high risk for occurrence of local relapses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10339668     DOI: 10.3892/ijo.14.6.1123

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  14 in total

Review 1.  Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis.

Authors:  Christopher Lieu; John Heymach; Michael Overman; Hai Tran; Scott Kopetz
Journal:  Clin Cancer Res       Date:  2011-09-27       Impact factor: 12.531

Review 2.  Molecular substratification of bladder cancer: moving towards individualized patient management.

Authors:  Anirban P Mitra
Journal:  Ther Adv Urol       Date:  2016-03-28

Review 3.  The role of angiogenesis in prostate and other urologic cancers: a review.

Authors:  J I Izawa; C P Dinney
Journal:  CMAJ       Date:  2001-03-06       Impact factor: 8.262

4.  Long non-coding RNA small nucleolar RNA host gene 1 knockdown suppresses the proliferation, migration and invasion of osteosarcoma cells by regulating microRNA-424-5p/FGF2 in vitro.

Authors:  Zhuokai Li; Xiaohe Wang; Shuofu Liang
Journal:  Exp Ther Med       Date:  2021-02-05       Impact factor: 2.447

Review 5.  Angiogenesis inhibitors: current strategies and future prospects.

Authors:  Kristina M Cook; William D Figg
Journal:  CA Cancer J Clin       Date:  2010-06-16       Impact factor: 508.702

6.  FGF2-mediated reciprocal tumor cell-endothelial cell interplay contributes to the growth of chemoresistant cells: a potential mechanism for superficial bladder cancer recurrence.

Authors:  Yule Chen; Guodong Zhu; Kaijie Wu; Yang Gao; Jin Zeng; Qi Shi; Peng Guo; Xinyang Wang; Luke S Chang; Lei Li; Dalin He
Journal:  Tumour Biol       Date:  2015-10-22

Review 7.  The role of fibroblast growth factors in tumor growth.

Authors:  M Korc; R E Friesel
Journal:  Curr Cancer Drug Targets       Date:  2009-08-01       Impact factor: 3.428

Review 8.  The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development.

Authors:  Paulina Wigner; Radosław Grębowski; Michał Bijak; Joanna Saluk-Bijak; Janusz Szemraj
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

9.  Pathobiology and chemoprevention of bladder cancer.

Authors:  Takuji Tanaka; Katsuhito Miyazawa; Tetsuya Tsukamoto; Toshiya Kuno; Koji Suzuki
Journal:  J Oncol       Date:  2011-09-15       Impact factor: 4.375

10.  Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients.

Authors:  Wen-Ya Zhou; Hong Zheng; Xiao-Ling Du; Ji-Long Yang
Journal:  Cancer Biol Med       Date:  2016-06       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.